Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1401 Neoplasms 1128 Prostatic Neoplasms 745 Lung Neoplasms 621 Colorectal Neoplasms 599 Carcinoma, Non-Small-Cell Lung 570 Carcinoma, Hepatocellular 414 Pancreatic Neoplasms 402 Leukemia, Myeloid, Acute 398 Stomach Neoplasms 356 Multiple Myeloma 326 Brain Neoplasms 311 Ovarian Neoplasms 310 Head and Neck Neoplasms 290 Neoplasm Metastasis 275 Precursor Cell Lymphoblastic Leukemia-Lymphoma 260 Rectal Neoplasms 254 Uterine Cervical Neoplasms 248 Recurrence 248 Melanoma 243 Esophageal Neoplasms 237 Glioblastoma 232 Squamous Cell Carcinoma of Head and Neck 231 Lymphoma 214 Sarcoma 209 Urinary Bladder Neoplasms 192 Colonic Neoplasms 192 Glioma 191 Triple Negative Breast Neoplasms 188 Hematologic Neoplasms 182

Interventions

pertuzumab 1 azeliragon 1 Trastuzumab 1 Docetaxel 1 Cyclophosphamide 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × OTHER × Cancer Related Cognitive Decline × Clear all

NCT05256745 2025-12-24

RAGE

Georgetown University

Phase 1/2 Recruiting

Cancer Related Cognitive Decline

Data powered by HemOnc (CC BY 4.0) Colophon ⚡